Filing Details

Accession Number:
0001375151-21-000072
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-03 19:20:57
Reporting Period:
2021-06-01
Accepted Time:
2021-06-03 19:20:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1375151 Zogenix Inc. ZGNX Pharmaceutical Preparations (2834) 205300780
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1543174 P Renee Tannenbaum C/O Zogenix, Inc.
5959 Horton Street, Suite 500
Emeryville CA 94608
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-01 5,000 $17.05 37,872 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.045 to $17.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.